- November 19, 2020
- Organized By:
Sponsored by the U.S. Food & Drug Administration (FDA)
Gina Hollenbeck, RN, BSN, President, ALK Positive Incorporated
Jennifer King, PhD, Chief Scientific Officer, GO2 Foundation for Lung Cancer
Erin Larkins, MD, Thoracic/Head and Neck Cancer Team Leader, Division of Oncology 2, Office of Oncologic Diseases, Center for Drug Evaluation and Research, FDA
Nichelle Stigger, M.A.Ed., Educator; Facilitator; Activist & Advocate; Lung Cancer Patient
Rea Blakey, Associate Director of External Outreach and Engagement, Oncology Center of Excellence, FDA
The public is invited, and registration is free for “Conversations on Cancer: Lung Cancer: It Can Happen to Anyone.” Every year in the US, as many as 20% of deaths due to lung cancer are in people who have never (or hardly ever) smoked – everyone is at risk. Many people, even healthcare providers, don’t suspect that lung cancer is likely to occur in nonsmokers, leading to delayed diagnosis and missed opportunities for early treatment. The prognosis, treatment options, and patient experience may also be different in nonsmoker patients with lung cancer. Anyone can get lung cancer. Please join the FDA Oncology Center of Excellence for a dynamic panel discussion about lung cancer in nonsmokers.
FDA plans to post archived webcasts after the meeting, however, in cases where the transmission was not successful, archived webcasts will not be available.
For additional information, please send an email to: OCE-Engagement@fda.hhs.gov